post-menopause

Patients

One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.

News

Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.